KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Revenue (2016 - 2026)

Johnson & Johnson's Revenue history spans 18 years, with the latest figure at $24.1 billion for Q1 2026.

  • On a quarterly basis, Revenue rose 9.91% to $24.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $96.4 billion, a 7.87% increase, with the full-year FY2025 number at $94.2 billion, up 6.05% from a year prior.
  • Revenue hit $24.1 billion in Q1 2026 for Johnson & Johnson, down from $24.6 billion in the prior quarter.
  • Over the last five years, Revenue for JNJ hit a ceiling of $24.6 billion in Q4 2025 and a floor of $19.8 billion in Q2 2022.
  • Historically, Revenue has averaged $21.9 billion across 5 years, with a median of $21.5 billion in 2023.
  • Biggest five-year swings in Revenue: decreased 14.32% in 2022 and later rose 9.91% in 2026.
  • Tracing JNJ's Revenue over 5 years: stood at $20.0 billion in 2022, then increased by 7.0% to $21.4 billion in 2023, then increased by 5.26% to $22.5 billion in 2024, then increased by 9.08% to $24.6 billion in 2025, then fell by 2.04% to $24.1 billion in 2026.
  • Business Quant data shows Revenue for JNJ at $24.1 billion in Q1 2026, $24.6 billion in Q4 2025, and $24.0 billion in Q3 2025.